Hologic (HOLX)
Hologic EBITDA TTM: 533.92M
View HOLX EBITDA TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
HOLX EBITDA TTM Rankings
| Overall | 79th percentile | 801 of 3957 |
| Sector | 87th percentile | 61 of 504 in Healthcare |
| Industry | 88th percentile | 9 of 76 in Medical Appliances & Equipment |
HOLX EBITDA TTM Range, Past 5 Years
| Minimum | -142.05M | Dec 2007 |
| Maximum | 679.18M | Sep 2011 |
| Average | 380.77M |
About EBITDA (TTM)
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization. EBITDA (TTM) is the sum of the last four quarters of EBITDA.
Investors often use EBITDA as a starting point for discounted cash flow analysis or to observe the performance of a business separately from its capital structure (debt vs equity financing structure).
Though EBITDA does form an excellent basis for cash flow analysis, some investors argue that it is a misleading measure since depreciation expenses are a real cost - old property, plant and equipment must eventually be replaced if a business plans to continue operations using those assets.
Learn More
You may also be interested in these HOLX related companies
HOLX News
Conditions of Growth, Economic Analysis - Research Report on SINA Corporation (USA) and Hologic, Inc.
May 25, 9:00AM Marketwire
May 25, 9:00AM Marketwire
Video of tomorrow's setups on $FWLT $ARUN $HOLX $ACI $HUN $WPRT - http://stks.co/3grp
about 24 days ago by greatstockpix
about 24 days ago by greatstockpix
Cantor Fitzgerald Maintains a 'Hold' on Hologic (HOLX); Acquisition Overshadows Challenging Quarter
May 01, 12:51PM Street Insider
May 01, 12:51PM Street Insider
Dougherty & Co Downgrades Hologic (HOLX) to Neutral; Four Reasons Not To Like The Deal
May 01, 10:28AM Street Insider
May 01, 10:28AM Street Insider
Needham & Company Maintains a 'Buy' on Hologic (HOLX); Qtr In-line; Acquisition on Gen-Probe is Transformational
May 01, 7:48AM Street Insider
May 01, 7:48AM Street Insider
$HOLX forms bearish "Diamond Top" chart pattern. http://stks.co/3aqb
about 29 days ago by RecogniaEvents
about 29 days ago by RecogniaEvents
GARP Research Maintains a 'Buy' on Conceptus (CPTS); Very Attractive Name in Health Care
Apr 30, 3:49PM Street Insider
Apr 30, 3:49PM Street Insider
#Hologic $HOLX to acquire Gen-Probe for about $3.72B in cash : http://stks.co/3aOH Quote http://stks.co/3aOI
about 30 days ago by TMXmoney
about 30 days ago by TMXmoney
RT @adamfeuerstein $HOLX acquiring $GPRO for $82.75 per share in cash. $3.7B deal.
about 30 days ago by StockTwits
about 30 days ago by StockTwits
Hologi $HOLX to acquire Gen-Probe $GPRO for $82.75 per share in cash, or a total enterprise value of approximately $3.7 billion.
about 30 days ago by Street_Insider
about 30 days ago by Street_Insider
$HOLX Hologic to Acquire Gen-Probe $GPRO - $SQNM could be bought out next i guess $ILMN ROCHE ?
about 30 days ago by biotech
about 30 days ago by biotech
$HOLX Hope those earnings are good, we need it back on an upward track
about 37 days ago by Bobsmith7
about 37 days ago by Bobsmith7
Hologic to Release Second Quarter Fiscal 2012 Operating Results on Monday, April 30, 2012
Apr 02, 7:00AM PR Newswire
Apr 02, 7:00AM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HOLX | 16.99 | +0.07 | +0.41% | 4.463B |
| HOLL | 1.24 | +0.00 | +0.00% | 28.74M |
| HOLI | 9.57 | +0.41 | +4.48% | 511.40M |
| HOKU | 0.0833 | -0.01 | -9.06% | 5.030M |
| HOGS | 9.74 | +0.25 | +2.63% | 356.06M |
| HOG | 48.49 | +0.97 | +2.04% | 10.94B |
| HOFT | 11.43 | -0.31 | -2.64% | 126.67M |
| HNZ | 53.59 | +0.09 | +0.17% | 17.11B |
| HNT | 26.69 | +0.25 | +0.95% | 2.190B |
| HNRG | 7.36 | +0.17 | +2.36% | 203.55M |
